The global human chorionic gonadotropin (hCG) market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). The major factors that are expected to fuel the growth of the market include the rising burden of infertility and hypogonadism globally. Moreover, increasing awareness about hCG among healthcare professionals and patients, coupled with the new product launches, is anticipated to accelerate the market growth during the forecast period. Moreover, the continuous R&D in gonadotropin extraction and preparation, coupled with favourable initiatives by the government and non-government organizations, are some other factors, that are anticipated to propel the growth of the market globally. However, the availability of substitutes and side effects associated with hCG is a factor that is anticipated to hinder the market growth during the forecast period. 

The human chorionic gonadotropin hormone is a placental hormone secreted by syncytiotrophoblast cells during pregnancy. These hormones stimulate the corpus luteum to produce progesterone. Moreover, the naturally extracted or recombinant human chorionic gonadotropin hormones are used in the treatment of infertility, male hypogonadism, and many other conditions. Furthermore, human chorionic gonadotropin is used as the marker in cancer, including choriocarcinoma, seminoma, germ cell tumors, and others.

hCG hormone plays a vital role after the formation of the embryo. Hence the usage of hCG in infertility treatment gained traction in both men and women. The growing burden of infertility across the globe is one of the factors that is anticipated to accelerate market growth. The recombinant hCG products are anticipated to have significant growth owing to the availability of different strengths and dosages for the individualization of therapy. Moreover, the demand for naturally extracted HCG hormone products is also on the rise, owing to the launch of new products and significant adoption.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered
• Regions Covered- Globally

Competitive Landscape: Merck & Co., Inc., Ferring B.V., and Fresenius SE & Co. KGaA, among others. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Human Chorionic Gonadotropin (hCG) Market Report by Segment

By Technology

• Natural Source Extraction 

• Recombinant

By Therapeutic Area

• Female Infertility Treatment

• Oligospermic 

• Male Hypogonadism

• Others

Global Human Chorionic Gonadotropin (hCG) Market by Region